BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 16782616)

  • 1. Long-term risk of oesophagitis, Barrett's oesophagus and oesophageal cancer in achalasia patients.
    Leeuwenburgh I; Haringsma J; Van Dekken H; Scholten P; Siersema PD; Kuipers EJ
    Scand J Gastroenterol Suppl; 2006; (243):7-10. PubMed ID: 16782616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oesophagitis is common in patients with achalasia after pneumatic dilatation.
    Leeuwenburgh I; Van Dekken H; Scholten P; Hansen BE; Haringsma J; Siersema PD; Kuipers EJ
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1197-203. PubMed ID: 16611281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus.
    Jankowski JA; Anderson M
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment of Barrett's oesophagus. A general survey.
    Petrakis IE; Sciacca V; Iascone C
    Acta Chir Belg; 2001; 101(2):53-8. PubMed ID: 11396051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?
    Quera R; O'Sullivan K; Quigley EM
    Endoscopy; 2006 Feb; 38(2):162-9. PubMed ID: 16479424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barrett's esophagus (BE) and carcinoma in the esophageal stump (ES) after esophagectomy with gastric pull-up in achalasia patients: a study based on 10 years follow-up.
    da Rocha JR; Ribeiro U; Sallum RA; Szachnowicz S; Cecconello I
    Ann Surg Oncol; 2008 Oct; 15(10):2903-9. PubMed ID: 18618179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study.
    Zagari RM; Fuccio L; Wallander MA; Johansson S; Fiocca R; Casanova S; Farahmand BY; Winchester CC; Roda E; Bazzoli F
    Gut; 2008 Oct; 57(10):1354-9. PubMed ID: 18424568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary inflammatory index and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study.
    Shivappa N; Hebert JR; Anderson LA; Shrubsole MJ; Murray LJ; Getty LB; Coleman HG
    Br J Nutr; 2017 May; 117(9):1323-1331. PubMed ID: 28571591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should patients with Barrett's oesophagus be kept under surveillance? The case for.
    Armstrong D
    Best Pract Res Clin Gastroenterol; 2008; 22(4):721-39. PubMed ID: 18656826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Barrett esophagus--an increasing problem].
    Berstad A; Hatlebakk JG; Giercksky KE
    Tidsskr Nor Laegeforen; 1998 Oct; 118(26):4100-3. PubMed ID: 9844516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barrett's oesophagus and carcinoma. Recent insights into its development and possible prevention.
    Peters FT; Kleibeuker JH
    Scand J Gastroenterol Suppl; 1993; 200():59-64. PubMed ID: 8016573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
    Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
    Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches to oesophageal columnar metaplasia (Barrett's oesophagus).
    Dent J
    Scand J Gastroenterol Suppl; 1989; 168():60-6. PubMed ID: 2694335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Revision needed of follow-up policy for Barrett's esophagus].
    Giard RW; Coebergh JW; Ouwendijk RJ
    Ned Tijdschr Geneeskd; 2002 Jan; 146(4):150-4. PubMed ID: 11845562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
    Frazzoni M; Manno M; De Micheli E; Savarino V
    Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation?
    Fitzgerald RC
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i21-6. PubMed ID: 15711004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastro-oesophageal reflux: the disease of the millennium.
    Navaratnam RM; Winslet MC
    Hosp Med; 1998 Aug; 59(8):646-9. PubMed ID: 9829061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
    Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: prevalence of Barrett's oesophagus and metaplasia at the gastro-oesophageal junction.
    Sharma P
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():48-54; discussion 61-2. PubMed ID: 15456464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus.
    Koek GH; Sifrim D; Lerut T; Janssens J; Tack J
    Gut; 2008 Aug; 57(8):1056-64. PubMed ID: 18403496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.